Cypress, CA, December 17, 2021 –(PR.com)– Intellego Technologies AB (publ) (Intellego) announces that the US evaluation of its photochromic dose technology, conducted by Ushio America, Inc. (Ushio) has now been completed. As a result of the evaluation, both Intellego and Ushio agree to expand the collaboration by introducing Dose222™, Ushio’s trademark and self-designed dosimeter manufactured by Intellego.

One of the world’s largest photonics solutions providers, Ushio expanded its ultraviolet product line with the Care222® series of filtered 222nm Far UV-C excimer lamp modules for microbial reduction applications. To support the Care222® series, Ushio has been testing and qualified Intellego’s dosimeter technology to indicate correct and repeatable low dose levels of 222nm radiation provided by Care222 technology. The dosimeters are available for end users and OEMs at Dose222.com.

“We are pleased with the opportunities…